Shandong Keyuan Pharmaceutical Co., Ltd. (SHE:301281)

China flag China · Delayed Price · Currency is CNY
37.89
-0.99 (-2.55%)
At close: Apr 29, 2026
26.81%
Market Cap 4.21B
Revenue (ttm) 448.33M
Net Income (ttm) 23.54M
Shares Out 108.29M
EPS (ttm) 0.21
PE Ratio 182.26
Forward PE n/a
Dividend 0.05 (0.13%)
Ex-Dividend Date May 20, 2025
Volume 3,160,223
Average Volume 4,406,127
Open 38.88
Previous Close 38.88
Day's Range 37.81 - 39.33
52-Week Range 25.87 - 53.99
Beta -0.13
RSI 47.03
Earnings Date Apr 16, 2026

About SHE:301281

Shandong Keyuan Pharmaceutical Co., Ltd. is involved in the research and development, manufacture, and marketing of chemical raw materials and their preparations. It offers gliclazide; metformin hydrochloride; isosorbide mononitrate; isosorbide dinitrate; lansoprazole; mecobalamin; ropivacaine hydrochloride; isoflurane; fluoxetine hydrochloride; clemastine fumarate; chlorpheniramine maleate; esmolol hydrochloride; nicotinamide-tinidazole; amlexanox; nisoldipine; qupibutu; clarithromycin lactobionate; propafenone hydrochloride; potassium diclofe... [Read more]

Sector Healthcare
Founded 2004
Employees 696
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301281
Full Company Profile

Financial Performance

In 2025, SHE:301281's revenue was 398.23 million, a decrease of -14.12% compared to the previous year's 463.72 million. Earnings were 16.55 million, a decrease of -72.62%.

Financial Statements

News

There is no news available yet.